We don't just advise; we build alongside founders. With extensive experience in launching and scaling AI-driven solutions in highly regulated healthcare, life science markets we provide hands-on support to help startups develop groundbreaking products while navigating regulatory compliance. Our team operates with a client-focused structure:
1. Each client receives a dedicated Commercialization Lead as the primary point of contact.
2. Specialist team members are engaged based on specific commercialization needs.
3. Cross-functional collaboration ensures comprehensive strategy development.
4. Weekly team coordination ensures consistent quality and knowledge sharing across engagements.\
Our key assets are our people, proprietary data, network, and instruments.
Strategic Advantage for our clients
• Exit Readiness: Align innovations with acquirer priorities through our dual perspective as former corporate leaders, startup founders, and investors.
• Market Access Accelerated: Leverage our commercialization playbooks, refined across 30+ engagements in Romania, Poland, Hungary, and other key markets, such as the UK, Switzerland, the US, and Germany.
• Investor Confidence: Robust financial modeling and introductions to venture capital networks.
Our multidisciplinary approach enables tailored support for startups at any commercialization stage, from regulatory strategy to post-launch scaling.
1. Top-notch Experts
• C-Suite Experience: 10–20 years in R&D, commercial, and investment roles, enabling realistic product validation and direct access to decision-makers at acquiring entities (pharma, hospitals, tech firms).
• 360-degree perspective: marketing, strategy, psychology, neuroscience, clinical, R&D, investment, and deep tech experience in major corporations and startups.
• Regulatory Success: Proven ability to navigate FDA/EMA and local market approvals and ISO 9001 compliance, exemplified by team-led exits and IP generation.
• Industry and startup experience: experience at top consulting companies, BIG 4 (Bain, BCG, PwC, IQVIA), life-science and MedTech companies (AstraZeneca, Novartis, Medtronic, Siemens Healthineers, Roche), and innovators like Proportunity and Cochlear.
• Academic pedigrees: Advanced degrees (MBA, PhD, and MSc) from Harvard University, University of Cambridge, MIT, Vrije University, Johns Hopkins, etc.
2. Global Network: Partnerships with 80+ investors, distributors, academic institutions, and corporates streamline market entry in key regions: the US and Western/Eastern Europe. This robust network enables us to connect our clients with the right investment opportunities, ensuring their growth and success. We have a footprint in the UK, US, Austria, Germany, Switzerland, Belgium, Romania, Poland, Hungary and Slovakia.
3. In-house filed agency
4. Proprietary databases, market intelligence, and commercialization methodologies developed for healthcare innovators
5. Pharmacovigilance tools and expertise
6. Impact: Demonstrated track record of accelerating market entry and revenue generation for healthcare innovations
7. Geographical footprint: Extensive experience working with healthcare innovations in RIS countries, the US, and Western Europe and multilingual capabilities that facilitate commercialization planning across different RIS markets.
Objectives
Topics
Service
Go-to-market strategy: from gap analysis to full-market launch, covering positioning, pricing, and operations in the UK, DE, US, and RO.
Executive Director, EIC innovation expert, EIC mentor at Human Data Insight Group
Bucharest, Romania
Service
We word directly with founders to refine their business and technology strategy while expanding into new markets.
Executive Director, EIC innovation expert, EIC mentor at Human Data Insight Group
Bucharest, Romania
Executive Director, EIC innovation expert, EIC mentor at Human Data Insight Group
Bucharest, Romania